[
  {
    "disease_id": "drkg:Disease::MESH:D003865",
    "drug_id": "drkg:Compound::DB00780",
    "disease_name": "major depressive disorder",
    "drug_name": "phenelzine",
    "source": "FDA_approved_psychiatric"
  },
  {
    "disease_id": "drkg:Disease::MESH:D001714",
    "drug_id": "drkg:Compound::DB08815",
    "disease_name": "bipolar disorder",
    "drug_name": "lurasidone",
    "source": "FDA_approved_psychiatric"
  },
  {
    "disease_id": "drkg:Disease::MESH:D019955",
    "drug_id": "drkg:Compound::DB00422",
    "disease_name": "hyperactive children who show excessive motor activity with accompanying conduct disorders",
    "drug_name": "methylphenidate",
    "source": "FDA_approved_psychiatric"
  },
  {
    "disease_id": "drkg:Disease::MESH:D019955",
    "drug_id": "drkg:Compound::DB00182",
    "disease_name": "hyperactive children who show excessive motor activity with accompanying conduct disorders",
    "drug_name": "amphetamine",
    "source": "FDA_approved_psychiatric"
  },
  {
    "disease_id": "drkg:Disease::MESH:D019955",
    "drug_id": "drkg:Compound::DB01576",
    "disease_name": "hyperactive children who show excessive motor activity with accompanying conduct disorders",
    "drug_name": "dextroamphetamine",
    "source": "FDA_approved_psychiatric"
  },
  {
    "disease_id": "drkg:Disease::MESH:D004827",
    "drug_id": "drkg:Compound::DB00906",
    "disease_name": "epilepsy",
    "drug_name": "tiagabine",
    "source": "FDA_approved_neurological"
  },
  {
    "disease_id": "drkg:Disease::MESH:D020325",
    "drug_id": "drkg:Compound::DB00571",
    "disease_name": "migraine",
    "drug_name": "propranolol",
    "source": "FDA_approved_neurological"
  },
  {
    "disease_id": "drkg:Disease::MESH:D020325",
    "drug_id": "drkg:Compound::DB00273",
    "disease_name": "migraine",
    "drug_name": "topiramate",
    "source": "FDA_approved_neurological"
  },
  {
    "disease_id": "drkg:Disease::MESH:D020325",
    "drug_id": "drkg:Compound::DB00321",
    "disease_name": "migraine",
    "drug_name": "amitriptyline",
    "source": "FDA_approved_neurological"
  },
  {
    "disease_id": "drkg:Disease::MESH:D020325",
    "drug_id": "drkg:Compound::DB14039",
    "disease_name": "migraine",
    "drug_name": "erenumab",
    "source": "FDA_approved_neurological"
  },
  {
    "disease_id": "drkg:Disease::MESH:D020325",
    "drug_id": "drkg:Compound::DB14041",
    "disease_name": "migraine",
    "drug_name": "fremanezumab",
    "source": "FDA_approved_neurological"
  },
  {
    "disease_id": "drkg:Disease::MESH:D020325",
    "drug_id": "drkg:Compound::DB14042",
    "disease_name": "migraine",
    "drug_name": "galcanezumab",
    "source": "FDA_approved_neurological"
  },
  {
    "disease_id": "drkg:Disease::MESH:D006333",
    "drug_id": "drkg:Compound::DB09292",
    "disease_name": "heart failure",
    "drug_name": "sacubitril",
    "source": "FDA_approved_cardiovascular"
  },
  {
    "disease_id": "drkg:Disease::MESH:D006949",
    "drug_id": "drkg:Compound::DB01432",
    "disease_name": "hyperlipidemia",
    "drug_name": "cholestyramine",
    "source": "FDA_approved_metabolic"
  },
  {
    "disease_id": "drkg:Disease::MESH:D009103",
    "drug_id": "drkg:Compound::DB00060",
    "disease_name": "multiple sclerosis",
    "drug_name": "interferon beta-1a",
    "source": "FDA_approved_autoimmune"
  }
]